Provided by Tiger Trade Technology Pte. Ltd.

China Pharma

0.9800
-0.0800-7.55%
Post-market: 0.9582-0.0218-2.22%19:59 EDT
Volume:309.10K
Turnover:313.15K
Market Cap:42.16M
PE:-2.33
High:1.05
Open:1.03
Low:0.9625
Close:1.06
52wk High:19.19
52wk Low:0.3818
Shares:43.02M
Float Shares:800.60K
Volume Ratio:0.81
T/O Rate:38.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4200
EPS(LYR):-0.7428
ROE:-20.99%
ROA:-9.36%
PB:1.17
PE(LYR):-1.32

Loading ...

Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 24, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Major Issues Report

8-K - Current report
Dec 05, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2022

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 30, 2022

Major Issues Report

8-K - Current report
Sep 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 29, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Mar 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 19, 2021

Correspondence

CORRESP [Cover] - Correspondence